文献速递妇科

前哨淋巴结活检在非子宫内膜样、高级别和/或深肌层浸润子宫内膜癌中的诊断准确性:土耳其妇科肿瘤组研究(TRSGO-SLN-006)

Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006).
PubMed 文献 · Gynecol Oncol · 2022-01-13

本研究为回顾性多中心研究,纳入244例非子宫内膜样组织学、3级子宫内膜样肿瘤和/或深肌层浸润的子宫内膜癌患者,评估前哨淋巴结(SLN)定位算法的诊断准确性。SLN检出率为91%,总体敏感度81.8%、阴性预测值95%、假阴性率18.2%;应用SLN算法后敏感度和阴性预测值分别提高至96.4%和98.9%。结论认为SLN算法在高危子宫内膜癌中诊断准确性高,但需长期生存研究后方可成为标准治疗。

要点

  • SLN算法在高危子宫内膜癌中敏感度96.4%、阴性预测值98.9%。
  • 3级肿瘤中SLN算法敏感度97.1%、阴性预测值98.9%、假阴性率2.9%。
  • 所有盆腔转移均被SLN算法检出,孤立腹主动脉旁转移率可忽略。

核心结论

  • SLN算法在高危子宫内膜癌中具有高诊断准确性,所有盆腔转移均被检出,孤立腹主动脉旁转移率可忽略。
  • 但该方法的长期生存研究是必要的,之后方能成为标准治疗。

研究设计与样本

  • 回顾性多中心研究,纳入244例非子宫内膜样组织学、3级子宫内膜样肿瘤和/或深肌层浸润的子宫内膜癌患者。
  • 切除SLN后,所有患者均接受盆腔±腹主动脉旁淋巴结清扫术。
  • 手术方式包括开腹、腹腔镜或机器人手术,示踪剂为吲哚菁绿(ICG)和亚甲蓝(MB)。

主要发现

  • 132例(54.1%)患者经开腹手术,152例(62.3%)接受双侧盆腔和腹主动脉旁淋巴结清扫术。
  • 222例(91%)患者检出至少1枚SLN;55例(22.5%)存在淋巴转移,45例有至少1枚转移性SLN。
  • 8例通过侧方特异性淋巴结清扫检出淋巴转移,2例为孤立腹主动脉旁转移。
  • SLN活检总体敏感度81.8%、阴性预测值95%、假阴性率18.2%;应用SLN算法后敏感度和阴性预测值分别提高至96.4%和98.9%。
  • 3级肿瘤中SLN算法敏感度97.1%、阴性预测值98.9%、假阴性率2.9%。

临床怎么用

  • 原文结论认为SLN算法在高危子宫内膜癌中诊断准确性高,但需长期生存研究后方可成为标准治疗。

局限性

  • 原文结论指出,在该方法成为标准治疗之前,长期生存研究是必要的。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This study aimed to evaluate the diagnostic accuracy of the sentinel lymph node (SLN) mapping algorithm in high-risk endometrial cancer patients. METHODS: Two hundred forty-four patients with non-endometrioid histology, grade 3 endometrioid tumors and/or tumors with deep myometrial invasion were enrolled in this retrospective, multicentric study. After removal of SLNs, all patients underwent pelvic ± paraaortic lymphadenectomy. Operations were performed via laparotomy, laparoscopy or robotic surgery. Indocyanine green (ICG) and methylene blue (MB) were used as tracers. SLN detection rate, sensitivity, negative predictive value (NPV) and false-negative rate (FNR) were calculated. RESULTS: Surgeries were performed via laparotomy in 132 (54.1%) patients and 152 (62.3%) underwent both bilateral pelvic and paraaortic lymphadenectomy. At least 1 SLN was detected in 222 (91%) patients. Fifty-five (22.5%) patients had lymphatic metastasis and 45 patients had at least 1 metastatic SLN. Lymphatic metastases were detected by side-specific lymphadenectomy in 8 patients and 2 patients had isolated paraaortic metastasis. Overall sensitivity, NPV and FNR of SLN biopsy were 81.8%, 95% and 18.2%, respectively. By applying SLN algorithm steps, sensitivity and NPV improved to 96.4% and 98.9%, respectively. For grade 3 tumors, sensitivity, NPV and FNR of the SLN algorithm were 97.1%, 98.9% and 2.9%. CONCLUSION: SLN algorithm had high diagnostic accuracy in high-risk endometrial cancer. All pelvic metastases were detected by the SLN algorithm and the isolated paraaortic metastasis rate was ignorable. But long-term survival studies are necessary before this approach becomes standard of care.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Altın D, Taşkın S, Ortaç F, et al. Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006). Gynecol Oncol. 2022. PMID: 35033380. doi:10.1016/j.ygyno.2022.01.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。